crevicular fluid 7 and gingival epithelium of chronic periodontitis patients. 8 Association of increased IL-33 level with periodontitis and alveolar bone resorption and loss was also reported. 8, 9 Recent findings indicated that IL-33 expression in cells of periapical lesion and radicular cyst may be involved in periapical inflammation 10, 11 which is caused by the pulpal infection. 12 Since the root apex and dental pulp are tightly interconnected tissues, communicating through periodontal pocket and apical foramen, 12, 13 
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Dental pulp (DP) forms dentin, whereas PDL is tooth-supportive connective tissue that ensures gently tooth anchorage to the alveolar bone, both providing tooth nutrition, protection and sensory perception, together contributing to the tooth longevity. [17] [18] [19] [20] Since PDL and DP are soft, connective tissues surrounded by hard, mineralized tissues, regulation of mineralization level is the main physiological demand within these tissues in order to adapt functional changes. 18, 21, 22 While
DPSCs contribute to replacement of damaged tissue and repair of complete tooth, PDLSCs have predominant role in tooth functions and development. 23 Resident DPSCs and PDLSCs respond to activation stimuli of dynamic microenvironment, governing tissue homeostasis, differentiation and regeneration. 18, 21, 22 Detailed understanding of functional behaviour of oral MSCs, both in vitro and in vivo, is still necessary regarding their potential use in cellular therapy and maxillofacial reconstruction.
As previous reports indicated different protein and gene expression patterns in human DPSCs and PDLSCs, 24, 25 in this study, we evaluated matrix mineralization by Alizarin red staining were estimated as previously described. 29 Light microscope (Olympus, Japan) was used to capture cells, while the mineralization level was quantified by densitometry in NIH-ImageJ software (LOCI, University of Wisconsin,
Madison, WI, USA).
| Cellular clonogenicity, proliferation and senescence in osteogenic differentiation settings
Colony-forming unit-fibroblast (CFU-F) assay was performed as we previously described for PDLSCs and DPSCs. 27, 28 CFU efficiency was determined as the percentage of colonies relative to total number of seeded cells in each well.
To determine ALP + CFU-Fs, termed as CFU-osteoblasts (CFU-O), cells were seeded in 24-well plates at concentration 100 cells/well and cultivated in GM in standard conditions during 7 days. 30 Then, the OM was added and incubation was continued for the next 7 days with or without IL-33 (100 ng/mL) when the colonies were stained for ALP activity. Percentage of CFU-O was expressed as ratio of ALP-positive CFUs/total CFUs*100.
Following the IL-33 (100 ng/mL) during 7-day osteogenic induction cell number, expression of intracellular proliferation marker 
| Western blot
After cultivation with IL-33 (100 ng/mL) at different time points, total protein extracts were isolated using lysis buffer. Same amounts of protein samples (concentration determined by BCA assay, Serva, Germany) were separated by SDS-PAGE and electrotransfered onto nitrocellulose membrane Hybond ECL (AppliChem, Germany).
Next, membranes were blocked in 4% nonfat milk (Serva) in TBST for 1 hour and subsequently incubated with primary antibodies:
mouse anti-GAPDH, anti-NF-κB and anti-β-catenin (Santa Cruz Biotechnology) overnight at 4°C. Protein bands were visualized using ECL reagent (Serva, Germany) after membrane incubation with anti-mouse HRP-conjugated antibody (Sigma-Aldrich) during 1 hour at room temperature. TA B L E 1 PCR primer sets used in experiments and 1 ng/mL of nuclear dye DAPI (Sigma-Aldrich) were added during 2 hours. Samples were examined using an epi-fluorescent microscope (Olympus, Japan). 
| Semiquantitative RT-PCR

| Statistical analysis
Intensities of immunoblots and RT-PCR bands were determined by ImageMaster TotalLab v1.11 software (Amersham Biotech).
Statistical significances ( * P < 0.05) were determined by Student's t test. Data were analysed and graphed using GraphPad Prism 6
Software (San Diego, CA). Results in graphs are presented as means ± SEM of four different samples (n = 4) from at least three independent experiments. Statistically significant difference in comparison with GM in the absence of IL-33 by t test: **P < 0.01; ***P < 0.01; or in comparison with OM in the absence of IL33: **P < 0.01; ***P < 0.01; or between PDLSCs and DPSCs: # P < 0.05; ## P < 0.01. E, For mRNA analysis, cells were cultivated in GM in the presence or absence of IL-33 (100 ng/mL) 24 h. As a gel loading control, GAPDH was used. Representative gels from three different samples (n = 3) are shown. Molecular weight standards are indicated in bp for PCR products. Results in graphs are presented as mean ± SEM from at least three independent experiments. Statistically significant differences between PDLSCs and DPSCs by t test: *P < 0.05; **P < 0.01 For mRNA analysis, and cells were cultivated in GM in the presence or absence of IL-33 (100 ng/mL) with or w/o 5 µM PDTC and 2 µM PNU during 24 h. As a gel loading control, GAPDH was used. Representative gels are shown. Molecular weight standards are indicated in bp for PCR products. Results in graphs represent relative gene expression of indicated gene and are shown as mean ± SEM of three different samples (n = 3) from at least three independent experiments. Statistically significant differences in comparison with control (untreated cells, set as 1) by t test: *P < 0.05; **P < 0.01; ***P < 0.001; or in comparison with IL-33 treatment: # P < 0.05 lesser extent than in PDLSCs ( Figure 5C ). On the other side, the presence of IL-33 stimulated expression of β-catenin in nucleus of both PDLSCs and DPSCs ( Figure 5C ). Obtained data imply that IL-33
| RE SULTS
regulates total protein expression level and importantly, subcellular localization of NF-κB and β-catenin in PDLSCs and DPSCs.
| Roles of NF-κB and β-catenin in IL-33-mediated PDLSCs and DPSCs proliferation
To evaluate involvement of NF-κB and β-catenin in IL-33-elevated On the other side, PNU itself supported proliferation of DPSCs, but not altering IL-33-stimulated proliferation of DPSCs ( Figure 6B ).
| Involvement of NF-κB and β-catenin in IL-33-stimulated pluripotency-associated marker expression
Results obtained for PDLSCs showed that PDTC inhibitor abolished Except Oct4B mRNA which was decreased by PNU, inhibitors did not alter IL-33-increased pluripotency marker gene expression.
| Roles of NF-κB and β-catenin in IL-33-affected osteogenesis
Our results showed that inhibitors' presence accomplished similar effects in PDLSCs ( Figure 8A , B) and DPSCs ( Figure 8D, E) . Namely,
PDTC and PNU inhibitors restored IL-33-reduced ALP activity and
Ca deposition levels in both cell types, without affecting the basal osteogenic differentiation ( Figure 8A, B, D, E) . Surprisingly, RT-PCR results did not reveal any significant effect of the presence of PDTC and PNU on Runx2 and ALP gene expression which stayed unaffected after IL-33 treatment in both cell type ( Figure 8C, F) .
| D ISCUSS I ON
The goal of this study was to evaluate the in vitro effects of IL-33
on main functional properties of PDLSCs and DPSCs, by addressing their basal stemness-related features, such as colony-forming capacity, proliferation, expression of pluripotency-associated markers and differentiation, especially referring to osteogenesis.
The PDLSCs and DPSCs used in our study, as resident population of progenitor cells of periodontal ligament and dental pulp, share characteristics with the bone marrow mesenchymal stem/stromal cells (BM-MSC), such as their colony-forming capacity,in vitro trilineage differentiation and surface markers expression. 31 Although
PDLSCs and DPSCs share close anatomical location, differences between these cells were observed in mineral composition generation, 32 stability after ectopic transplantation, 33 hard tissue formation and alkaline phosphatase activity, 34 proteome 24 and gene expression. 35 As PDLSCs and DPSCs respond to specific stimuli triggered by inflammation or injury, which affect cell recruitment and proliferation in dental regions, 36 it is probable that their responsiveness all passages, as it was also reported. 24 Both investigated cell types maintained their growth rate during prolonged in vitro culture, as it has previously been revealed. 38 Since PDL and DP inhabit in soft 46 Our study revealed predominantly Ki67 cytoplasmic staining in dental stem cells and similar was found in ASCs. 45 Since there are few evidences regarding Ki67 expression in dental stem cells, it would be reasonable to find out precise biological role of nuclear and cytoplasmic Ki67.
Activation of NF-κB by IL-33 has been shown in different cell types, such as fibroblast-like synoviocytes, 47 endothelial cells 48 and human HEK293RI cells. 49 Here, for the first time, we showed that IL-33 stimulated activation of NF-κB in PDLSCs and DPSCs. The observed IL-33 increased proliferation of DPSCs, achieved via NF-κB activation, when cultivated in the presence of osteogenic stimuli, is in agreement with previous report demonstrating that inflammatory cytokine IFN-γ-promoted DPSC proliferation via NF-κB. 50 Observed involvement of NF-κB activation in the inhibition of ALP activity and matrix mineralization achieved by IL-33 treatment were also in accordance with previously reported data for PDLSCs 51 and DPSCs.
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The β-catenin, as part of canonical Wnt signalling, controls neural stem cell proliferation 52 and has important role in tooth biology. 53 Here, IL-33-elevated proliferation of PDLSCs was achieved by β-cat- on the other imply that the role of β-catenin signalling in osteogenesis is not fully comprehended. However, inhibition of osteogenic differentiation is mediated through NF-κB activation, which further on promoted β-catenin ubiquitination and degradation in human and mouse MSCs. 56 Therefore, it can be assumed that cooperation of NF-κB and β-catenin may exist and be involved in regulation of dental stem cell functions, too.
We found that IL-33 decreased β-galactosidase activity in PDLSCs and DPSCs simultaneously with stimulation of their proliferation capacity. The inhibition of β-galactosidase activity was additionally strengthened in OM, which can independently reduce β-galactosidase activity in both cell types. Important stimulator of osteogenesis in OM, ascorbic acid-2-phosphate increases proliferative capacity by attenuating senescence and expression of reactive oxygen species in human osteoarthritic osteoblast. 57 Whether the antioxidative effect is also mechanism of the action of IL-33 needs to be further investigated. Promotion of cell divisions and increased ALP activity in human and mouse BM-MSCs could be the mechanism through which reduction in senescence can be achieved. 58 However, our data indicated that the inhibitory effect of IL-33 treatment on osteogenesis was not achieved through antiproliferative or pro-ageing mechanism.
Important outcome from our study is the observation that IL-33 stimulated protein and gene expression of pluripotency-associated markers, OCT4, SOX-2 and NANOG in both cell populations inves- Human PDLSCs and DPSCs retain stemness genes and proliferation for prolonged time during in vitro cultivation, 38 and expression of stemness markers was often associated with their origin from neural crest (stem) cells which migrate and establish stem cell pools through the anatomical sites such as dental region or even bone marrow.
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Our previous study demonstrated that DPSCs and PDLSCs express pluripotency markers in higher extent than other adult stem cells, such as adipose tissue progenitors. 63 The elevated pluripotency marker expression accompanied with IL-33-stimulated proliferation and clonogenicity of PDLSCs and DPSCs is in accordance with previous studies demonstrating overexpression of OCT-4A, 64 SOX-2 65 and NANOG 66 associated with increased proliferation of DPSCs or clonogenic capacity of human BM-MSCs. 67 Liu et al also reported that OCT-4A overexpression in DPSCs leads to upregulation of other pluripotency genes, such as Oct4B1, SOX-2, NANOG, Klf4 and c-Myc, thus indicating possible close mutual cooperation of these transcriptional factors. 64 Contrary to OCT-4A, the role of OCT4B in pluripotency is not clear. However, it may be assumed that OCT4B actually governs self-renewal and maintenance of tissue homeostasis within adult tissues. 68 Previous studies indicated that OCT4B might be involved in cellular stress response 69 and antiapoptotic activity in cancer cells. 70, 71 Importantly, OCT4B may indirectly be increased in dental pulp tissues and dental pulp cells exposed to proinflammatory factors, where it has been suggested that OCT4B represents a antiapoptotic mediator and subsequently may be the important factor in dental regeneration. 72 Our results indicate that IL-33 increases expression of OCT4B mRNA expression in both PDLSCs and DPSCs. Whether IL-33-stimulated OCT4B has some regulatory role in dental stem cell phenotype and behaviour needs to be additionally investigated. Previously, the role of NF-κB signalling in maintenance of pluripotency of human iPSC was shown, as the augmented NF-κB activity correlated with increased expression of OCT-4A and NANOG, sustaining human iPSC in undifferentiated state. 73 Our analysis also showed that the activation of NF-κB is involved in IL-33-upregulated Oct4 and NANOG expression in PDLSCs and Oct4, SOX-2 and NANOG in DPSCs. Additionally, IL-33- 
